Catalyst Pharmaceuticals Inc. Stock Falls 3.7%, Underperforms Peers

Dow Jones

Sep 04

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Catalyst Pharmaceuticals Inc. shed 3.7% to $19.79 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 1.0% to 21,497.73 and the Dow Jones Industrial Average falling 0.1% to 45,271.23.

This was the stock's second consecutive day of losses.

Catalyst Pharmaceuticals Inc. closed 25.5% short of its 52-week high of $26.58, which the company achieved on June 9th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson remained unchanged, Pfizer Inc. fell 0.8% to $24.79, and Abbott Laboratories rose 0.55% to $132.18.

Trading volume totaled 2.7 million, compared to the 50-day average of 1.4 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 03, 2025 16:35 ET (20:35 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2564311167"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2564311167\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2564311167?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-04 04:35","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2564311167","market":"sg","top_or_hot":-1,"title":"Catalyst Pharmaceuticals Inc. Stock Falls 3.7%, Underperforms Peers","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     Shares of Catalyst Pharmaceuticals Inc. shed 3.7% to $19.79 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 1.0% to 21,497.73 and the Dow Jones Industrial Average falling 0.1% to 45,271.23. \n</p>\n<p>\n     This was the stock's second consecutive day of losses. \n</p>\n<p>\n     Catalyst Pharmaceuticals Inc. closed 25.5% short of its 52-week high of $26.58, which the company achieved on June 9th. \n</p>\n<p>\n     The stock underperformed when compared to some of its peers, as Johnson &amp; Johnson remained unchanged, Pfizer Inc. fell 0.8% to $24.79, and Abbott Laboratories rose 0.55% to $132.18. \n</p>\n<p>\n     Trading volume totaled 2.7 million, compared to the 50-day average of 1.4 million. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 03, 2025 16:35 ET (20:35 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Catalyst Pharmaceuticals Inc. Stock Falls 3.7%, Underperforms Peers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCatalyst Pharmaceuticals Inc. Stock Falls 3.7%, Underperforms Peers\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-09-04 04:35</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  This article was automatically generated by Dow Jones using technology from Automated Insights. \n</p>\n<p>\n     Shares of Catalyst Pharmaceuticals Inc. shed 3.7% to $19.79 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 1.0% to 21,497.73 and the Dow Jones Industrial Average falling 0.1% to 45,271.23. \n</p>\n<p>\n     This was the stock's second consecutive day of losses. \n</p>\n<p>\n     Catalyst Pharmaceuticals Inc. closed 25.5% short of its 52-week high of $26.58, which the company achieved on June 9th. \n</p>\n<p>\n     The stock underperformed when compared to some of its peers, as Johnson &amp; Johnson remained unchanged, Pfizer Inc. fell 0.8% to $24.79, and Abbott Laboratories rose 0.55% to $132.18. \n</p>\n<p>\n     Trading volume totaled 2.7 million, compared to the 50-day average of 1.4 million. \n</p>\n<p>\n  Data source: Dow Jones Market Data, FactSet \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  September 03, 2025 16:35 ET (20:35 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CPRX","symbol_name":"Catalyst Pharmaceutical Partners","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2564311167","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2564311167","pubTimestamp":1756931700,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Catalyst Pharmaceuticals Inc. shed 3.7% to $19.79 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 1.0% to 21,497.73 and the Dow Jones Industrial Average falling 0.1% to 45,271.23.This was the stock's second consecutive day of losses.Catalyst Pharmaceuticals Inc. closed 25.5% short of its 52-week high of $26.58, which the company achieved on June 9th.The stock underperformed when compared to some of its peers, as Johnson & Johnson remained unchanged, Pfizer Inc. fell 0.8% to $24.79, and Abbott Laboratories rose 0.55% to $132.18.Trading volume totaled 2.7 million, compared to the 50-day average of 1.4 million.","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"CPRX":"Catalyst Pharmaceutical Partners"},"translate_title":"Catalyst Pharmaceuticals Inc.股价下跌3.7%，表现逊于同行","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CPRX":1},"content_text":"This article was automatically generated by Dow Jones using technology from Automated Insights. \n\n\n     Shares of Catalyst Pharmaceuticals Inc. shed 3.7% to $19.79 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 1.0% to 21,497.73 and the Dow Jones Industrial Average falling 0.1% to 45,271.23. \n\n\n     This was the stock's second consecutive day of losses. \n\n\n     Catalyst Pharmaceuticals Inc. closed 25.5% short of its 52-week high of $26.58, which the company achieved on June 9th. \n\n\n     The stock underperformed when compared to some of its peers, as Johnson & Johnson remained unchanged, Pfizer Inc. fell 0.8% to $24.79, and Abbott Laboratories rose 0.55% to $132.18. \n\n\n     Trading volume totaled 2.7 million, compared to the 50-day average of 1.4 million. \n\n\n  Data source: Dow Jones Market Data, FactSet \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  September 03, 2025 16:35 ET (20:35 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}